Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.90
-0.39 (-0.16%)
AAPL  258.90
-0.14 (-0.05%)
AMD  206.15
+1.47 (0.72%)
BAC  56.12
-0.06 (-0.12%)
GOOG  330.50
+4.49 (1.38%)
META  651.28
+5.22 (0.81%)
MSFT  477.52
-0.59 (-0.12%)
NVDA  184.97
-0.07 (-0.04%)
ORCL  196.53
+7.38 (3.90%)
TSLA  444.34
+8.54 (1.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.